Large-scale testing (Phase 3)Active Not RecruitingNCT06396065What this trial is testingPhase III Study of AK112 for NSCLC PatientsWho this might be right forNon-Squamous Non-small Cell Lung Cancer Summit Therapeutics 420
Testing effectiveness (Phase 2)Study completedNCT00988936What this trial is testingEfficacy Study of [F-18]RGD-K5 Positron Emission Tomography (PET) as a Tool to Monitor Response to an Anti-angiogenic DrugWho this might be right forMetastatic Breast CancerMetastatic Colon/Rectum CancerNon-squamous Non-small Cell Lung Cancer Siemens Molecular Imaging 35
Testing effectiveness (Phase 2)Looking for participantsNCT05498428What this trial is testingAmivantamab in Participants With Advanced or Metastatic Solid Tumors Including Epidermal Growth Factor Receptor (EGFR)-Mutated Non-Small Cell Lung CancerWho this might be right forCarcinoma, Non-small-Cell Lung Janssen Research & Development, LLC 520
Not applicableStudy completedNCT00525057What this trial is testingDalteparin in Preventing DVT in Participants With CancerWho this might be right forBone SarcomaFemur FractureLymphoma+4 more M.D. Anderson Cancer Center 65
Testing effectiveness (Phase 2)Study completedNCT01394939What this trial is testingRecombinant Vaccinia Virus Administered Intravenously in Patients With Metastatic, Refractory Colorectal CarcinomaWho this might be right forColorectal CarcinomaCRC Jennerex Biotherapeutics 52
Early research (Phase 1)Ended earlyNCT00376519What this trial is testingUmbilical Cord Blood T-Regulatory Cell Infusion Followed by Donor Umbilical Cord Blood Transplant in Treating Patients With High-Risk Leukemia or Other Hematologic DiseasesWho this might be right forGraft Versus Host DiseaseLeukemiaLymphoma+3 more Masonic Cancer Center, University of Minnesota 3
Early research (Phase 1)Study completedNCT00005946What this trial is testingChemotherapy Plus Donor White Blood Cell Infusion in Treating Patients With Relapsed Hematologic Cancer Following Donor Peripheral Stem Cell TransplantationWho this might be right forLeukemiaLymphomaMultiple Myeloma and Plasma Cell Neoplasm+1 more University of Maryland, Baltimore
Not applicableStudy completedNCT00296023What this trial is testingDonor Stem Cell Transplant in Treating Older or Frail Patients With Hematologic CancerWho this might be right forChronic Myeloproliferative DisordersLeukemiaLymphoma+2 more University of California, San Francisco 25
Large-scale testing (Phase 3)UnknownNCT03500380What this trial is testingRC48-ADC Administered Intravenously to Patients With HER2-Positive Metastatic Breast Cancer With or Without Liver MetastasesWho this might be right forBreast NeoplasmsBreast DiseasesCapecitabine+3 more RemeGen Co., Ltd. 301
Testing effectiveness (Phase 2)Study completedNCT04300790What this trial is testingStudy to Evaluate the Effect of Metformin in the Prevention of HG in HR[+]/HER2[-] PIK3CA-mut Advanced BC PatientsWho this might be right forBreast Cancer MedSIR 69
Early research (Phase 1)UnknownNCT05643417What this trial is testingCamrelizumab Combined With Bevacizumab and HAIC in Patients With Metastatic Liver Cancer Who Failed Standard TherapyWho this might be right forMetastatic Liver Cancer Fudan University 80
Not applicableStudy completedNCT04789980What this trial is testingGood Choice of pALliative Chemotherapy to Patient With Pancreatic Cancer ; GemcitAbine Therapy vs FOLFORINOX therapYWho this might be right forLocally Advanced Pancreatic CancerMetastatic Pancreatic Cancer Boryung Pharmaceutical Co., Ltd 799
Testing effectiveness (Phase 2)Study completedNCT04508803What this trial is testingCombination of HX008 And Niraparib in GErm-line-mutAted Metastatic Breast CancerWho this might be right forTreatment Efficacy Fudan University 37
Testing effectiveness (Phase 2)Study completedNCT02278133What this trial is testingStudy of WNT974 in Combination With LGX818 and Cetuximab in Patients With BRAF-mutant Metastatic Colorectal Cancer (mCRC) and Wnt Pathway MutationsWho this might be right forMetastatic Colorectal Cancer Array BioPharma 20
Early research (Phase 1)Study completedNCT02364492What this trial is testingA Phase I Study of a Therapeutic Vaccine Candidate in Patients With Localized Breast Cancer at High-Risk of RelapseWho this might be right forBreast Neoplasms Institut Pasteur 20
Large-scale testing (Phase 3)Study completedNCT02574455What this trial is testingTrial of Sacituzumab Govitecan in Participants With Refractory/Relapsed Metastatic Triple-Negative Breast Cancer (TNBC)Who this might be right forBreast Cancer Gilead Sciences 529
Testing effectiveness (Phase 2)UnknownNCT04131621What this trial is testingNivolumab/Ipilimumab in Second Line CUP-syndromeWho this might be right forCancer of Unknown Primary Site University Hospital Heidelberg 194
Large-scale testing (Phase 3)Study completedNCT04812509What this trial is testingEfficacy and Safety of MW032 and Xgeva® in Subjects With Bone Metastases From Solid TumorsWho this might be right forBone Metastases Mabwell (Shanghai) Bioscience Co., Ltd. 708
Testing effectiveness (Phase 2)Ended earlyNCT01562899What this trial is testingMEK162 and AMG 479 in Patients With Selected Solid TumorsWho this might be right forMetastatic Pancreatic AdenocarcinomaBRAF Mutated Melanoma Pfizer 77
Testing effectiveness (Phase 2)Ended earlyNCT00589602What this trial is testingT-Cell Depletion, Donor Hematopoietic Stem Cell Transplant (HSCT), and T-Cell Infusions in Treating Patients With Hematologic Cancer or Other DiseasesWho this might be right forChronic Myeloproliferative DisordersLeukemiaLymphoma+4 more The Cleveland Clinic 13